United States · Series C startup
2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Valuation: $1.5B, Mar 2026
Follow Anaconda and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$172Mraised across 2 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Omega Funds
Sabadell Venture Capital
Ysios Capital
Innogest CapitalReported by FinSMEs and 1 other
Anaconda filed one raise, $2.6M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Anaconda's own website and the SEC filings it signed: 1 founder, 8 on the team.
On the board, as filediBarry LibertGerald Chan
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Insight PartnersLSabadell Asabys Health Innovation Investments SCRL
General Catalyst
CitibankOmega Funds
MubadalaSabadell Venture CapitalYsios CapitalInnogest CapitalMissing a round, or an investor who was in one? Tell us.
These 2 firms list Anaconda as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Anaconda's investors include Insight Partners, Sabadell Asabys Health Innovation Investments SCR, General Catalyst, Citibank and Omega Funds, and 4 more on record. Insight Partners led its latest round.
Anaconda has raised $172M across 2 rounds since 2019.
Anaconda's most recent round was a Series C of $150M in Jul 2025, led by Insight Partners.
Its most recent round, $150M in Jul 2025, is also its largest on record.
Anaconda's first round on record, in Dec 2019, was backed by Sabadell Asabys Health Innovation Investments SCR, Omega Funds and Sabadell Venture Capital and 2 others.
Anaconda's latest named round is a Series C, in Jul 2025.
Anaconda is based in the United States.
Sabadell Asabys Health Innovation Investments SCR led the Series B in 2019; Insight Partners led the Series C in 2025.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
